Artikel-artikel mengenai Therapeutic Goods Administration

Menampilkan semua artikel

Embedded medical devices will continue to be vulnerable to cybersecurity threats. The pacemaker depicted is not made by Abbott’s. REUTERS/Fabrizio Bensch

Three reasons why pacemakers are vulnerable to hacking

Pacemakers are Internet of Things devices for the human body, but they're still not particularly secure.
The Australian drugs regulator is overhauling the health claims made by suppliers of complementary medicines, including homeopathic therapies. And some curious options are up for discussion. from www.shutterstock.com

New complementary medicine health claims lack evidence, so why are they even on the table?

Would you trust a complementary medicine described as "vermifuge", "vulnerary" or "emmenagogue"? That's what new labelling proposes and not everyone's happy about it.
Classifying e-cigarettes as a nicotine replacement therapy could help the tobacco industry influence health policy. from www.shutterstock.com

How e-cigarettes could ‘health wash’ the tobacco industry

Classing e-cigarettes as quit smoking aids could help rebrand the tobacco industry as a legitimate player in health policy. Here's why we should be concerned.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached. EPA/Erik S. Lesser

Why biologics were such a big deal in the Trans Pacific Partnership

Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
Off-label use is when an approved medicine is prescribed for a different reason, at a different dose, or in different patient groups than originally intended. Benny Lin/Flickr

Explainer: why are off-label medicines prescribed?

The off-label use of medicines is not illegal and it doesn't mean regulators have specifically "disapproved" its use. But there are a number of issues to consider before using a medicine off-label.
Trade minister Andrew Robb attends negotiations for the Trans Pacific Partnership in Sydney last year. Dan Himbrechts/AAP Image

How the battle over biologics helped stall the Trans Pacific Partnership

Over the next few weeks, the trade minister will be under intense pressure to renege on the government’s commitment to reject anything in the Trans Pacific Partnership that could undermine the PBS.
Despite assurances from Minister for Trade and Investment Andrew Robb, the TPP could negatively affect Australian health policy. Dan Himbrechts/AAP

Leaked TPP investment chapter shows risks to Australia’s health

The latest part of the TPP to be leaked is its investment chapter. And like almost everything we know about the secretive negotiations for the agreement, it provides plenty of cause for concern.
This product is being sold despite being removed from the Australian Register of Therapeutic Goods by the TGA. Ken Harvey

TGA, once again, fails to reign in shonky weight-loss product

I submitted a complaint about the promotion of “FatBlaster Reducta” (ARTG no: 176366) to the Therapeutic Goods Administration in March 2011. The product is a “complementary medicine” containing an extract…

Kontributor teratas

Lebih banyak